Salivary Gland Cancer Clinical Trials

42 clinical trials for Salivary Gland Cancer across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• DESTINY-PANTUMOUR04 — RECRUITING
• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — RECRUITING · PHASE2
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas — RECRUITING · PHASE2
• The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers — RECRUITING
• Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers — RECRUITING · PHASE1
• A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers — RECRUITING · PHASE2
• Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) — RECRUITING · PHASE2
• Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer — NOT_YET_RECRUITING · PHASE1
• 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• APG-115 in Salivary Gland Cancer Trial — ACTIVE_NOT_RECRUITING · PHASE1
• Amivantamab in Adenoid Cystic Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) — COMPLETED · PHASE2
• Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes — COMPLETED · NA
• Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer — COMPLETED · PHASE2
• Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) — ACTIVE_NOT_RECRUITING · PHASE2
• Enhanced Assistance During Radiotherapy for Unmet Essential Needs — COMPLETED · NA
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC — ACTIVE_NOT_RECRUITING · PHASE1
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) — TERMINATED · PHASE1
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• Androgen Deprivation Therapy in Advanced Salivary Gland Cancer — COMPLETED · PHASE2
• Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers — NOT_YET_RECRUITING
• Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients — OTHER · PHASE2
• Activity of Sorafenib in Salivary Gland Cancer — COMPLETED · PHASE2
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — COMPLETED · PHASE1
• Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC — OTHER · PHASE1
• Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients — COMPLETED · PHASE2
• PSMA-PET Imaging Before and After ADT in Advanced SDC Patients — OTHER · NA
• Survival With Patients Treated With Salivary Gland Cancer — COMPLETED
• 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma — WITHDRAWN · PHASE2
• Cell-free Tumor DNA in Head and Neck Cancer Patients — OTHER · NA
• Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study — OTHER · PHASE2
• Cabozantinib in Advanced Salivary Gland Cancer Patients — TERMINATED · PHASE2
• Stereotactic Body Radiotherapy for Head and Neck Tumors — COMPLETED · PHASE4
• PSMA-PET Imaging for Advanced ACC/SDC — COMPLETED · NA
• Iressa Study in Patients With Salivary Gland Cancer — COMPLETED · PHASE2
• Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer — OTHER · PHASE3
• A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer — TERMINATED · PHASE1
• A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands — COMPLETED · PHASE2
• Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis — OTHER

Refine this search